United States · Funded startup
6 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 6 rounds since 2010, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Nov 2012
Reported by streetinsider.comSEC filing: $6.0M sold, first sale May 2011
Reported by fis.dowjones.comSEC filing: $12M sold, first sale Jul 2010
Hatteras Venture Partners
Clarus Ventures
Quaker Partners
The Vertical GroupReported by fiercebiotech.comSEC filing: $12M sold, first sale Jul 2010
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Nov 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Clarus VenturesHatteras Venture Partners
PfizerHealthCare VenturesQuaker PartnersAmgenThe Vertical Group
Nextech VentureMissing a round, or an investor who was in one? Tell us.
TetraLogic Pharmaceuticals's investors include Clarus Ventures, Hatteras Venture Partners, Pfizer, HealthCare Ventures and Quaker Partners, and 5 more on record.
TetraLogic Pharmaceuticals has raised $73M across 6 rounds since 2010.
TetraLogic Pharmaceuticals's most recent round was a Debt of $5.0M in Dec 2012.
TetraLogic Pharmaceuticals's largest round on record is $32M (Series C), in Aug 2010.
TetraLogic Pharmaceuticals's first round on record, in Aug 2010, was backed by Hatteras Venture Partners, Clarus Ventures and HealthCare Ventures and 5 others.
TetraLogic Pharmaceuticals's latest named round is a Debt, in Dec 2012.
TetraLogic Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·